TNGX
TNGX
US87583X1090
Tango Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
4.01B EUR
5.26B EUR
3.02B EUR
1.2B EUR
Enterprise Value
2.82B EUR
4.95B EUR
2.89B EUR
1.13B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-14.13x
--
--
--
Price to Sales
74.61x
97.82x
52.92x
21.13x
Price to Book
3.91x
5.14x
7.7x
3.48x
EV/Revenue
52.47x
91.99x
50.72x
19.75x
EV/EBITDA
-21.01x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.79%
-2.74%
-4.73%
-8.15%
ende